Skip to content

UNH · UNITEDHEALTH GROUP INC

33 filings

10-K

UNH 10-K Annual Reports

UNITEDHEALTH GROUP INC - 33 annual reports

Filing record · 2016–202610-K1110-Q328-K173

2025
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2025
UNITEDHEALTH GROUP INC. (UNH) reported its 2025 fiscal year results, highlighting continued revenue growth across its segments, particularly in UnitedHealthcare and Optum Rx. Despite a strong top-line performance, the company's earnings from operations saw a significant decline of 41% compared to the prior year. This decrease was primarily attributed to elevated medical cost trends, which outpaced pricing assumptions, and the impact of restructuring and other actions totaling $2.5 billion. Key areas impacting profitability include increased medical costs driven by higher care activity, provider pricing, and the effects of the Inflation Reduction Act on Medicare Part D plans. UnitedHealthcare experienced a 16% revenue increase, driven by Medicare Advantage and fee-based commercial offerings, but its earnings from operations fell by 40% due to the aforementioned cost pressures and specific business adjustments. Optum, while growing revenues by 7%, saw its earnings from operations decrease by 43%, largely due to challenges within Optum Health, which reported a net loss from operations. This segment was impacted by Medicare Advantage funding reductions and medical cost trends. Optum Rx, however, demonstrated strong performance with a 16% revenue increase and a 23% rise in earnings from operations, benefiting from higher script volumes and a gain on a business deconsolidation. The company also managed its capital effectively, with significant cash flows from operations and a robust balance sheet, while continuing to return capital to shareholders through dividends and share repurchases.
Mar 2, 2026
2024
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2024
UnitedHealth Group Inc. (UNH) presented a solid financial performance for the year ended December 31, 2024, marked by an 8% increase in total revenues to $400.3 billion. This growth was primarily driven by strong performance in its Optum segment, particularly Optum Rx and Optum Health, which saw revenue increases of 15% and 11% respectively, alongside a 6% rise in UnitedHealthcare's revenue. Despite a reported net loss of $7.98 billion on a diluted EPS basis (or $15.51 per share) due to a significant loss on the sale of its Brazil operations and other South American businesses ($8.3 billion), the company demonstrated operational resilience. Key operational highlights include serving a larger member base through UnitedHealthcare's domestic offerings, with a 5% increase in total individuals served. The company also managed the significant impact of the Change Healthcare cyberattack, incurring $2.2 billion in direct response costs and an estimated $867 million in business disruption impacts for Optum Insight, while providing over $9 billion in interest-free loans to care providers. Management remains focused on navigating medical cost trends, government funding pressures in Medicare Advantage, and ongoing investments in value-based care models and technology, positioning the company for continued strategic growth.
Feb 27, 2025
2023
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2023
UnitedHealth Group (UNH) reported strong performance in its 2023 10-K filing, demonstrating robust revenue growth and operational expansion. The company's dual-pronged strategy, leveraging the strengths of its UnitedHealthcare and Optum segments, continues to drive market leadership and shareholder value. UnitedHealthcare saw significant growth, particularly in Medicare Advantage and Medicaid offerings, while Optum continued its expansion across Health, Insight, and Rx, showcasing strong revenue increases in all segments. The company managed medical costs effectively, despite some inflationary pressures and increased care activity in specific senior segments, maintaining a healthy medical care ratio. Financially, UNH generated substantial cash flow from operations, supporting significant investments in acquisitions, share repurchases, and dividend increases. The company's balance sheet remains strong, with ample liquidity and a well-managed debt-to-equity ratio. Management highlighted ongoing efforts in technology and data analytics to enhance patient care and operational efficiency, while also acknowledging the evolving regulatory landscape and cybersecurity risks. The company also disclosed a cybersecurity incident, for which investigations are ongoing, but as of the filing date, no material financial impact had been determined. Overall, UNH presents a resilient business model with diversified revenue streams and a clear strategy for continued growth and profitability.
Feb 28, 2024
2022
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2022
UnitedHealth Group Inc. (UNH) demonstrated robust financial performance in 2022, with consolidated revenues increasing by 13% to $324.2 billion. This growth was driven by strong performance across both its UnitedHealthcare and Optum segments, with Optum revenues growing 17% and UnitedHealthcare revenues growing 12%. The company also saw a significant increase in earnings from operations, up 19%, and diluted earnings per share rose 17% to $21.18. The company continues to expand its reach, serving nearly 1.1 million more people through its UnitedHealthcare offerings, particularly in community-based and senior care. The Optum segment, comprising Optum Health, Optum Insight, and Optum Rx, showed substantial growth, reflecting its expanding role in care delivery, data analytics, and pharmacy services. Cash flow from operations remained strong at $26.2 billion, and the company maintained a healthy return on equity of 27.2%, indicating efficient use of shareholder capital.
Feb 24, 2023
2021
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2021
UnitedHealth Group Inc. (UNH) reported strong financial performance for the fiscal year ending December 31, 2021. The company demonstrated robust revenue growth, increasing by 12% year-over-year, driven by expansion in both its UnitedHealthcare and Optum segments. UnitedHealthcare saw a 11% revenue increase, largely due to growth in Medicare Advantage, Medicaid, and commercial offerings, serving approximately 2.1 million more people domestically. The Optum segment exhibited even stronger growth with a 14% revenue increase, particularly fueled by Optum Health's 36% revenue surge from value-based care and acquisitions, alongside solid performance in Optum Insight and Optum Rx. Net earnings attributable to common shareholders grew by 12% to $17.3 billion, or $18.08 per diluted share. The company's return on equity remained strong at 25.2%. UnitedHealth Group also generated substantial cash flow from operations, amounting to $22.3 billion, which supported significant investments in acquisitions, share repurchases, and dividend payments. The company returned $10.3 billion to shareholders through dividends and share repurchases, underscoring its commitment to shareholder value. The report also highlights the company's ongoing investments in technology and care delivery models, positioning it for continued growth in the evolving healthcare landscape.
Feb 15, 2022
2020
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2020
UnitedHealth Group (UNH) reported strong performance in its 2020 10-K filing, reflecting robust growth across its key segments despite the ongoing challenges of the COVID-19 pandemic. The company demonstrated resilience, with total revenues increasing by 6% to $257.1 billion and earnings from operations growing by 14% to $22.4 billion. This growth was largely driven by the UnitedHealthcare segment, which saw a 4% revenue increase, particularly benefiting from expansion in Medicare Advantage and Medicaid programs. The Optum segment was a significant contributor, with revenues surging by 21% to $136.3 billion, fueled by strong performance in OptumHealth and OptumRx. The company maintained a healthy return on equity of 24.9% and generated substantial cash flows from operations ($22.2 billion), underscoring its financial strength. UnitedHealth Group continued to return capital to shareholders through increased dividends and share repurchases. While the pandemic did introduce some operational impacts, such as temporary deferral of care affecting certain service volumes, the company effectively managed these challenges through strategic customer assistance programs and cost management initiatives. Looking ahead, UNH is poised for continued growth, further supported by strategic acquisitions, including the significant pending acquisition of Change Healthcare.
Mar 1, 2021
2019
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2019
UnitedHealth Group Inc. (UNH) demonstrated robust financial performance in 2019, with revenues reaching $242.2 billion, a 7% increase year-over-year, driven by growth across both its UnitedHealthcare and Optum platforms. Earnings from operations saw a significant 13% rise to $19.7 billion, and diluted earnings per share increased by 18% to $14.33, reflecting effective cost management and strategic growth initiatives. The company's diversified business model, encompassing health benefits through UnitedHealthcare and health services through Optum, continues to be a key strength. UnitedHealthcare experienced growth, particularly in its Medicare & Retirement segment, while Optum saw strong performance across OptumHealth, OptumInsight, and OptumRx, highlighting the success of its diversified service offerings and acquisitions. The company also returned substantial capital to shareholders through increased dividends and share repurchases, signaling confidence in its financial health and future prospects.
Feb 14, 2020
2018
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2018
UnitedHealth Group Inc. reported strong performance in its 2018 fiscal year, demonstrating significant revenue growth driven by its UnitedHealthcare and Optum segments. The company's diversified business model, encompassing health benefits and health services, continues to yield positive financial results. Key financial highlights include substantial revenue increases and robust earnings from operations, reflecting effective cost management and a growing customer base. The company's strategic focus on leveraging data and technology, coupled with clinical expertise across its platforms, positions it well for continued expansion and market leadership. Investors can look to UnitedHealth Group's consistent financial performance and its strategic initiatives as indicators of its ongoing strength and future growth potential.
Feb 12, 2019
2017
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2017
UnitedHealth Group's 2017 10-K filing reveals a strong financial performance driven by robust growth across its UnitedHealthcare and Optum segments. The company demonstrated significant revenue increases, bolstered by expansion in Medicare Advantage and Medicaid, alongside consistent growth in its health services arm, Optum. Diluted earnings per share saw a substantial jump, partly attributed to the Tax Cuts and Jobs Act, which positively impacted the company's tax rate. Strategically, UnitedHealth Group continues to leverage its dual platform approach, with UnitedHealthcare offering diversified health benefits and Optum providing a suite of health services. The company's commitment to innovation is evident in its increasing engagement with value-based care models and its continuous investment in technology and data analytics. Despite facing pressures in Medicare Advantage funding and the return of the Health Insurance Industry Tax, UnitedHealth Group maintains a positive outlook, focusing on operational efficiency and member-focused care to drive future growth and profitability.
Feb 13, 2018
2016
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2016
UnitedHealth Group Inc.'s (UNH) 2016 10-K filing highlights a strong year of growth, with total revenues reaching $184.84 billion, an 18% increase year-over-year, driven by robust performance across both its UnitedHealthcare and Optum segments. Diluted earnings per share saw a significant 21% increase to $7.25, reflecting effective cost management and strategic growth initiatives. The company continues to expand its reach, serving an additional 2.1 million people domestically through its UnitedHealthcare benefits. Optum also demonstrated substantial growth, with revenues increasing by 24%, bolstered by its Health, Insight, and Rx businesses. Despite a challenging regulatory environment and pressures on Medicare Advantage funding, UNH maintained strong operational execution. The company highlighted its proactive approach to managing medical costs through integrated care management and value-based payment models, which are increasingly being adopted across provider networks. Furthermore, UNH is strategically navigating changes in the healthcare landscape, including a reduced participation in individual public exchanges, while continuing to invest in its diversified business platforms for long-term growth and value creation for shareholders.
Feb 8, 2017
2015
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2015
UnitedHealth Group Inc. (UNH) demonstrated strong revenue growth in 2015, with consolidated revenues increasing by 20% to $157.1 billion, largely driven by the significant acquisition of Catamaran Corporation, which bolstered the OptumRx segment. The company also saw a 10% increase in UnitedHealthcare revenues, reflecting growth in people served and price increases. Earnings from operations saw a 7% rise, with Optum demonstrating robust growth of 30%, partially offset by a 3% decrease in UnitedHealthcare earnings. Diluted earnings per share improved by 5% to $6.01, and cash flow from operations increased by 21% to $9.7 billion. The company's diversified business model, with its two platforms, UnitedHealthcare (providing health benefits) and Optum (providing health services), continues to drive performance. UnitedHealthcare experienced growth across Medicare & Retirement, Community & State, and Employer & Individual segments, though Global operations saw a decline. Optum's segments, particularly OptumRx due to the Catamaran acquisition and OptumHealth and OptumInsight through organic growth, all reported significant revenue and earnings increases. Despite the positive financial trends, investors should note the company's ongoing engagement with regulatory changes, particularly related to the Affordable Care Act, and the impact of Medicare Advantage funding pressures. The company also incurred significant losses and established premium deficiency reserves for its individual exchange-compliant products. The company's strategic focus on expanding value-based care arrangements and leveraging its technology and data analytics capabilities through the Optum platform remain key drivers for future growth.
Feb 9, 2016
2014
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2014
UnitedHealth Group's 2014 10-K filing highlights a company with diversified operations across health benefits (UnitedHealthcare) and health services (Optum). The report details significant revenue growth, driven by expansion in senior and public markets within UnitedHealthcare and strong performance across all Optum businesses, particularly OptumRx. Despite revenue growth, the company faced pressures from the Affordable Care Act (ACA) fees, Medicare Advantage funding reductions, and increased spending on specialty medications, which impacted earnings from operations for the UnitedHealthcare segment. Key financial highlights include a 7% increase in consolidated revenues to $130.5 billion, with Optum revenues growing 25%. Diluted earnings per share increased by 4% to $5.70. The company also continued its focus on returning capital to shareholders through dividends and share repurchases, while managing its balance sheet with a debt-to-debt-plus-equity ratio of 34.9%. The filing also notes significant investments in technology and clinical capabilities, positioning the company for future growth in an evolving healthcare landscape.
Feb 10, 2015
2013
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2013
UnitedHealth Group (UNH) reported strong performance in its 2013 10-K filing, demonstrating significant revenue growth driven by both its UnitedHealthcare and Optum segments. The company's diversified business model, encompassing health benefits and health services, contributed to an 11% increase in total revenues to $122.5 billion. Earnings from operations grew by 4% to $9.6 billion. A key strategic move mentioned is the upcoming business realignment in 2014, which aims to further capitalize on Optum's technology and business processing capabilities. The company also highlighted its proactive approach to managing medical costs and its ongoing efforts to adapt to the evolving healthcare landscape, including the impact of the Patient Protection and Affordable Care Act. Investors would note the company's continued expansion, particularly through acquisitions like Amil in Brazil, which significantly boosted international revenue. The Optum segment showed particularly robust growth, with revenues up 26% and earnings from operations up 61%, underscoring the strategic importance of its health services arm. The filing also details the company's capital management strategies, including share repurchases and dividend increases, reflecting a commitment to shareholder returns.
Feb 12, 2014
2012
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2012
UnitedHealth Group Inc. (UNH) demonstrated robust revenue growth in 2012, an increase of 9% to $110.6 billion, driven by strong performance in both its UnitedHealthcare and Optum platforms. The company reported net earnings of $5.5 billion, a 7% increase year-over-year, with diluted earnings per share rising 12% to $5.28. This growth was fueled by expanded medical enrollment, particularly in Medicare & Retirement and Community & State segments, and strategic acquisitions, notably the significant purchase of Amil in Brazil. The company's diversified business model, encompassing health benefits (UnitedHealthcare) and health services (Optum), positions it to navigate the evolving healthcare landscape. Despite challenges such as increased medical costs driven by hospital price inflation and utilization trends, UnitedHealth Group managed its medical care ratio effectively, keeping it stable. The company also actively returned capital to shareholders through share repurchases and increased dividends, signaling confidence in its financial stability and future prospects. The report also details the company's ongoing efforts to adapt to the complexities of the Health Reform Legislation, which is expected to shape the future of the healthcare industry.
Feb 7, 2013
2011
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2011
UnitedHealth Group's 2011 10-K report highlights a year of substantial revenue growth, reaching $101.9 billion, an 8% increase over 2010, driven by strong performance in both its UnitedHealthcare and Optum segments. The company reported net earnings of $5.14 billion, a 11% increase year-over-year, with diluted earnings per share of $4.73. This growth was supported by an increase in UnitedHealthcare's membership by 1.6 million individuals and a significant 21% revenue increase from the Optum health services business. The company's strategic focus on affordability, consumer empowerment, and integrated health services continues to drive results. Despite rising medical costs, which increased by 8% and were influenced by hospital price increases, UnitedHealth Group managed its medical care ratio effectively, maintaining it at 80.8%. The company also demonstrated strong operational cash flow, increasing by 11% to $7 billion. Key financial indicators such as return on equity (18.9%) and a strengthened debt-to-debt-plus-equity ratio (29.1%) indicate a healthy financial position. The report also underscores the company's active share repurchase program and a consistent increase in shareholder dividends.
Feb 9, 2012
2010
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2010
UnitedHealth Group (UNH) reported strong financial performance for the fiscal year ending December 31, 2010. The company experienced significant revenue growth, driven by its Health Benefits segment, particularly in the public and senior markets, and by premium rate increases reflecting underlying medical cost trends. Despite an increase in operating costs, UNH demonstrated improved profitability, with earnings from operations and net earnings both showing substantial year-over-year growth. The company also highlighted its strategic business realignment efforts in early 2011, aimed at better responding to market dynamics. Investors should note UNH's substantial participation in government health care programs, such as Medicare Advantage and Medicaid, which are subject to regulatory changes and reimbursement adjustments. The company's robust cash flow from operations and strong balance sheet position provide financial flexibility. Management is actively managing medical costs and operational efficiencies to navigate the evolving healthcare landscape, including the implications of the recently enacted Health Reform Legislation.
Feb 10, 2011
2009
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2009
In fiscal year 2009, UnitedHealth Group (UNH) demonstrated resilience and growth across its diversified health and well-being businesses. The company reported a significant increase in total revenues to $87.1 billion, driven by strong performance in its Health Benefits segment, particularly within the public and senior markets, and continued expansion in its OptumHealth and Ingenix services. Despite facing a challenging economic environment and evolving healthcare regulations, UNH managed its medical costs effectively, resulting in improved earnings from operations to $6.4 billion and diluted net earnings per share of $3.24. The company also continued its commitment to shareholder returns through share repurchases and dividends. UnitedHealth Group's strategic focus on simplifying healthcare administration, leveraging data and technology, and offering consumer-centric solutions positions it well for future growth. The company's robust financial position, evidenced by strong cash flows from operations and a solid balance sheet, allows for continued investment in its diverse business units and strategic acquisitions. Investors can look to UNH's diversified model as a strength, enabling it to navigate the complexities of the healthcare landscape while delivering value.
Feb 10, 2010
2008-A
UNITEDHEALTH GROUP INC Annual Report (Amendment), Year Ended Dec 31, 2008
UnitedHealth Group Inc. (UNH) filed this 10-K/A amendment primarily to correct a typographical error regarding 2008 Medicare Part D revenue, revising it from $4.6 billion to $5.8 billion. The overall financial performance presented in the filing shows a mixed picture for the year ended December 31, 2008. While total revenues grew to $81.2 billion, up from $75.4 billion in 2007, net earnings saw a significant decline to $3.0 billion from $4.7 billion in the prior year. This decrease in profitability, coupled with a substantial increase in investing activities, potentially reflecting strategic acquisitions, warrants investor attention. The company's balance sheet shows growth in total assets to $55.8 billion, an increase from $50.9 billion in 2007, and a rise in total debt. Despite the increased leverage, the Debt-to-Total-Capital ratio remains manageable. Investors should monitor the impact of recent acquisitions, such as Sierra Health Services and Fiserv Health, on future earnings and operational integration, especially in the context of the overall economic environment of 2008.
Feb 18, 2009
2008
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2008
UnitedHealth Group Inc. (UNH) reported significant revenue growth of 8% to $81.2 billion for the fiscal year ended December 31, 2008. This growth was primarily driven by acquisitions and premium rate increases in its Health Care Services segment. However, net earnings decreased by 36% to $3.0 billion, or $2.40 per diluted share, compared to 2007. This decline in profitability was attributed to higher operating costs, including significant settlement expenses related to historical stock option practices, and increased medical costs that outpaced premium rate adjustments in some areas. The company actively pursued strategic acquisitions in 2008, including Sierra Health Services, Inc. and Fiserv Health, Inc., which expanded its market presence and service offerings. Despite a challenging economic environment and a 30% decrease in diluted EPS, UNH maintained a strong balance sheet with significant cash and investments, demonstrating resilience. The company's diversified business model, encompassing health benefits and health services, positions it to navigate industry pressures and regulatory changes, though investors should monitor the impact of ongoing healthcare reform discussions and economic conditions on future performance.
Feb 11, 2009
2007
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2007
UnitedHealth Group Inc. (UNH) reported robust financial performance for the fiscal year ended December 31, 2007. The company demonstrated significant growth in revenues and earnings, driven by its diversified health and well-being services. Key segments like Health Care Services, OptumHealth, Ingenix, and Prescription Solutions all contributed to this positive trend. The company's strategic focus on enhancing health system performance and improving overall health outcomes for its approximately 70 million members appears to be yielding strong results, reflected in a 12% increase in net earnings over the prior year. Investors can take confidence in UNH's ability to navigate a complex regulatory environment while achieving substantial growth. The company's proactive approach to managing medical costs and its disciplined approach to capital allocation, including significant share repurchases, further underscore its financial strength. While facing the typical industry challenges and regulatory scrutiny, UNH's consistent performance and strategic investments in its various business units position it favorably for continued success.
Feb 21, 2008
2006
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2006
UnitedHealth Group (UNH) filed its 2006 10-K with significant disclosures concerning a restatement of financial statements due to historical stock option granting practices. The company identified a material weakness in internal controls related to stock option administration and accounting. Despite these challenges, the company reported robust financial performance in 2006, with revenues increasing 54% to $71.5 billion and net earnings growing 35% to $4.2 billion, driven by acquisitions (notably PacifiCare) and the successful launch of its Medicare Part D program. Investors should note the significant impact of the stock option investigation, which led to restated financials and a material weakness in internal controls that management believes has since been remediated. The company's growth was fueled by strategic acquisitions and expansion into the Medicare Part D market, which contributed substantially to revenue growth. While operating margins saw a slight decrease due to business mix changes, overall profitability and cash flow remained strong.
Mar 6, 2007
2005
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2005
UnitedHealth Group Inc. (UNH) has filed its 2005 10-K report, highlighting a year of robust growth and strategic expansion. The company experienced a significant 22% increase in revenues, reaching $45.4 billion, driven by strong organic growth and strategic acquisitions, most notably the acquisition of PacifiCare Health Systems in December 2005. This acquisition substantially expanded UNH's market presence, particularly in the Western United States, and broadened its service offerings, especially in senior and specialty care. Financially, UNH demonstrated strong performance with net earnings of $3.3 billion, a 28% increase over the prior year, and diluted earnings per share of $2.48. The company's operating margin improved to 11.8%, reflecting effective cost management and operational efficiencies across its diversified segments, including Health Care Services, Uniprise, Specialized Care Services, and Ingenix. With a solid balance sheet and significant cash reserves, UNH is well-positioned for continued growth and strategic investments in the evolving healthcare landscape.
Feb 24, 2006
2004
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2004
UnitedHealth Group Inc. reported strong financial performance for the fiscal year 2004, demonstrating diversified growth across its business segments. The company achieved a significant increase in revenues, growing by 29% to $37.2 billion, largely driven by strategic acquisitions of Oxford Health Plans and Mid Atlantic Medical Services. Net earnings rose by 42% to $2.6 billion, with diluted earnings per share increasing by 33% to $3.94. The company's diversified business model, encompassing Health Care Services, Uniprise, Specialized Care Services, and Ingenix, continues to drive value. The Health Care Services segment, in particular, saw substantial growth due to acquisitions and increased enrollment in Medicare Advantage and Medicaid programs. UnitedHealth Group also highlighted its focus on improving the healthcare system through administrative simplification, evidence-based medicine, and data-driven decision-making, positioning it well for future opportunities and challenges in the evolving healthcare landscape.
Mar 1, 2005
2003
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2003
UnitedHealth Group's 2003 Form 10-K (filed March 15, 2004) shows a very strong year: revenues rose 15% to $28.8 billion, earnings from operations climbed 34% to $2.9 billion, and net earnings reached $1.8 billion, up 35%. Diluted EPS was $2.96, up 39% from $2.13. The consolidated medical care ratio improved to 81.4% from 83.0%, and the operating cost ratio fell to 16.9% from 17.5%, driving the consolidated operating margin up to 10.2% from 8.7%. Return on shareholders' equity was 39.0%. Growth was broad-based: Health Care Services (UnitedHealthcare, Ovations, AmeriChoice) earnings rose 40%, while Uniprise, Specialized Care Services and Ingenix also grew. The balance sheet expanded substantially through acquisitions. Golden Rule Financial was acquired in November 2003 for $495 million in cash, and Mid Atlantic Medical Services (MAMSI) was acquired in February 2004 for roughly $2.7 billion, paid in 36.4 million shares plus about $800 million in cash. Total assets rose to $17.6 billion and debt totaled $2.0 billion, with a debt-to-total-capital ratio of 27.8%, which management intends to keep at or below 30%. The company repurchased 33 million shares for about $1.6 billion during 2003 and still has authorization for 45 million more. Investors should weigh several risks. Management notes that a 1% change in commercial medical costs would move net earnings by about $75 million. Ovations depends on the AARP contract, which generated about $4.1 billion in premium revenue. The company also faces ongoing managed care class-action litigation, including the In Re Managed Care Litigation (MDL 1334) with a trial set for September 2004, and the AMA suit. Management states these are not expected to be materially adverse, but outcomes remain uncertain.
Mar 15, 2004
2002
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2002
UnitedHealth Group's 2002 Form 10-K (filed March 19, 2003) reports a record year: revenues rose 7% to $25.0 billion, earnings from operations grew 40% to $2.2 billion, and net earnings reached $1.35 billion, up 48% on a reported basis. Diluted EPS was $4.25, up 52% from $2.79, and return on shareholders' equity improved to 33.0% from 24.5%. Much of the improvement came from operational efficiencies, a shift toward higher-margin fee-based products, and improved commercial medical cost ratios (the consolidated medical care ratio fell from 85.3% to 83.0%). Part of the margin gain also came from withdrawing from unprofitable risk-based contracts and Medicare+Choice markets. Note that the comparison includes the FAS No. 142 change: goodwill amortization of $93 million in 2001 was eliminated, so the company presents a comparable basis showing diluted EPS growth of about 38%. Balance sheet and cash flow remained solid. Operating cash flow was $2.4 billion, up 31%. Cash and investments totaled $6.3 billion, and debt-to-total-capital was 28.5%, within management's 25–30% target. The company repurchased 22.3 million shares for about $1.8 billion and acquired AmeriChoice in September 2002 for roughly $577 million in stock and cash. Goodwill rose to $3.4 billion. Key risks disclosed include Medicare+Choice reimbursement pressures, which led to market withdrawals and a 35% drop in UnitedHealthcare Medicare enrollment, dependence on the AARP contract ($3.7 billion in premiums), and the ongoing MDL 1334 managed care class action litigation involving ERISA and RICO claims, which management does not expect to be material.
Mar 19, 2003
2001
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2001
UnitedHealth Group's 2001 Form 10-K, filed April 1, 2002, reports a strong year driven by revenue growth and margin expansion. Consolidated revenues reached a record $23.5 billion (up 11%), earnings from operations rose 31% to $1.6 billion, and diluted EPS was $2.79 (up 33%). The consolidated operating margin improved to 6.7% from 5.7%, mainly from productivity gains and a mix shift toward higher-margin fee-based products. Return on shareholders' equity rose to 24.5% from 19.0%. Growth was broad across segments. Health Care Services (UnitedHealthcare and Ovations) generated $20.5 billion in revenue, with commercial premium yield increases above 13%, while Uniprise, Specialized Care Services and Ingenix all grew revenue and operating earnings at double-digit rates. Medicare+Choice remains a managed risk: the company withdrew from counties affecting 56,000 members in 2001 and 57,000 more in 2002, and the AARP contract (about $3.5 billion in annual premiums) is a major concentration. Cash flow from operations exceeded $1.8 billion, and the company repurchased 19.6 million shares for about $1.1 billion. The balance sheet grew more leveraged. Debt rose to $1.6 billion, and the debt-to-total-capital ratio increased to 28.9% from 24.7%, close to management's 30% ceiling. The filing also flags an ongoing set of class action and multi-district litigation (MDL No. 1334) alleging ERISA and RICO violations, along with regulatory exposure (HIPAA compliance deadlines in 2002-2003). Management states that none of these matters is expected to have a material adverse effect, though the risks are disclosed in detail.
Apr 1, 2002
2000-A
UNITEDHEALTH GROUP INC Annual Report (Amendment), Year Ended Dec 31, 2000
UnitedHealth Group (UNH) closed 2000 as its strongest year on record, with revenues of $21.1 billion (up 8% reported, roughly 12% in continuing markets), operating earnings of $1.2 billion (up 27%), and diluted EPS of $2.19 as reported, or $2.10 excluding nonrecurring tax benefits and a gain on UnitedHealth Capital dispositions. Return on shareholders' equity rose to 19.0% from 14.1%, and operating cash flow exceeded $1.5 billion, up 28%. Margin improvement drove the gains: the consolidated medical care ratio fell to 85.4% from 85.7%, and the operating cost ratio fell to 16.7% from 17.1%. Health Care Services, the largest segment, grew earnings 28%, while Uniprise, Specialized Care Services and Ingenix also posted strong growth. The company remained highly cash-generative while returning capital to shareholders. It repurchased 31.0 million shares for $1.2 billion in 2000, leaving authorization for 28.4 million more shares, and executed a two-for-one stock split in December 2000. Total cash and investments were $5.1 billion, and senior debt was rated A by S&P and Fitch and A3 by Moody's. Total debt rose to $1.2 billion after a $400 million 7.5% note issuance. Management expects the 2001 operational realignment to be completed and cites its existing liquidity as sufficient for current needs. Investors should weigh the concentration of AARP Medicare Supplement business, which contributed about $3.5 billion in premiums, and the 7% decline in UnitedHealthcare's Medicare enrollment as the company exited unprofitable counties. Forward-looking risks include state and federal regulation, the effects of acquisitions and divestitures, and the realignment charges still being absorbed. At the March 12, 2001 market price of $59.66, the share price implied a market capitalization near $19 billion for non-affiliate shares.
Apr 2, 2001
2000
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2000
UnitedHealth Group (UNH) closed 2000 as its strongest year in company history, per management. Revenues rose to a record $21.1 billion (up 8% reported, roughly 12% in continuing markets after exiting certain Medicare and geographic markets). Earnings from operations reached $1.2 billion, up 27%, and net earnings were $736 million, or $2.19 diluted EPS (about $2.10 excluding a $14 million tax benefit and a $27 million gain tied to UnitedHealth Capital dispositions). Return on shareholders' equity rose to 19.0% from 14.1%, and operating cash flow exceeded $1.5 billion, up 28%. Growth was broad across segments. Health Care Services (UnitedHealthcare and Ovations) grew revenue 6% to $18.7 billion, with operating margin improving to 4.0%, driven by commercial premium yield gains and a lower commercial medical care ratio of 84.1%. Uniprise, Specialized Care Services and Ingenix grew revenue 15%, 34% and 45%, respectively. The company also continued to shrink its Medicare footprint deliberately, with Medicare enrollment down 7%, and it is still completing its 1998 operational realignment, with $65 million of reserves remaining. Investors should weigh the risks the filing highlights. Medical costs are priced prospectively and margins are thin, so small changes in the medical care ratio can move results. The company faces numerous class actions alleging ERISA and RICO violations, along with heavy government scrutiny of Medicare and FEHBP operations, although management does not expect a material adverse effect. Its AARP contract (about $3.5 billion in annual premium) and Medicare operations remain concentration risks. Share repurchases of $1.2 billion in 2000 and a 2-for-1 split were executed, and the stock closed the year at $61.38, roughly 2.3 times its year-end 1999 level, as market capitalization reached $19.5 billion.
Mar 30, 2001
1999
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 1999
UnitedHealth Group's 1999 10-K reports its strongest year on record. Revenue rose 13% to $19.6 billion, and earnings from operations reached $943 million, up 10% from 1998's adjusted $858 million. Diluted EPS was $3.20, up 22%, and return on equity improved to 14.1% from 11.9%. Operating cash flow hit a record $1.2 billion. Management attributes growth to about 9% commercial premium yield increases, the AARP Medicare Supplement contract, and acquisitions in dental (DBP), clinical research (WCT), and HealthPartners of Arizona. Segment operating earnings rose 20% to $953 million, with every segment growing. The key risk areas are medical cost management and Medicare. The consolidated medical care ratio improved to 85.7% from 87.2%, but 1998 included a $175 million Medicare contract-loss charge. The Medicare business remains a concern: management withdrew from 135 counties over 1999-2000, Medicare enrollment fell 9%, and the Medicare medical care ratio was still 89.6% in 1999. The company also faces a 1998 operational realignment with $127 million in remaining reserves, pending securities class-action settlement (covered by insurers), and ongoing regulatory exposure including proposed patient-rights legislation and ERISA/RICO class actions. Balance sheet strength is solid, with $4.7 billion in cash and investments and about $1.5 billion in statutory capital at regulated subsidiaries. Shareholders' equity declined to $3.9 billion from $4.0 billion because of a $983 million buyback that retired 19.4 million shares. Total debt rose to $991 million. Management is credit-rated A/A3, and the Company expects its liquidity to cover operating needs.
Mar 30, 2000
1998-A
UNITEDHEALTH GROUP INC Annual Report (Amendment), Year Ended Dec 31, 1998
UnitedHealth Group's 1998 10-K shows a year of sharp contrast: underlying results were strong, but reported results were a net loss. Revenues rose 47% to a record $17.4 billion, driven mainly by the $3.5 billion AARP Medicare supplement program and same-store commercial enrollment growth in UnitedHealthcare. Excluding $725 million of realignment charges and $175 million of Medicare and medical cost charges (plus a $20 million preferred redemption premium), management reports earnings from operations of $858 million and diluted EPS of $2.62, up 16%. As reported, the company lost $214 million applicable to common shareholders, or $1.12 per diluted share, versus earnings of $2.26 in 1997. The quality of earnings is the central issue for investors. The medical care ratio rose to 87.2% from 84.3%, with Medicare running at 92.0% after $111 million of contract losses in 13 of 24 Medicare markets. The company responded by withdrawing Medicare products from 86 counties effective January 1, 1999, and the filing discloses that re-entry is barred for five years. Balance sheet and liquidity remain solid: cash and investments of $4.4 billion, over $1.0 billion of operating cash flow, shareholders' equity of $4.0 billion, and debt of $708 million after a $500 million preferred stock redemption. Management expects about $300 million of annual cost savings from the realignment by 2000, though only about $75 million is expected in 1999. The filing also flags material risks. Six securities class action suits and two opt-out pension fund suits, seeking compensatory damages (the pension funds seek about $12.1 million), arise from statements about Medicare profitability during February to August 1998. The Year 2000 remediation is scheduled for completion by September 30, 1999, at a projected total cost of $79 million. Heavy regulation of Medicare, Medicaid and HMOs, along with ongoing government audits, remains an overhang.
Apr 22, 1999
1998
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 1998
UnitedHealth Group's 1998 10-K shows a company that grew revenue sharply but posted a net loss, driven by a $725 million operational realignment charge and $175 million of Medicare and commercial medical cost charges. Revenues rose 47% to a record $17.4 billion, largely from the $3.5 billion AARP Medicare supplement program and same-store UnitedHealthcare growth. Excluding the special charges, management reports underlying earnings from operations of $858 million, net earnings to common of $509 million, and diluted EPS of $2.62, up 16% to 18% over 1997. Reported results were a net loss applicable to common shareholders of $214 million, or $(1.12) per diluted share, including a $20 million preferred redemption premium. The key concern for investors is margin pressure. The consolidated medical care ratio rose to 87.2% from 84.3%, and the Medicare business posted a 92.0% ratio after contract losses in 13 of 24 markets. Management withdrew Medicare products from 86 counties effective January 1, 1999, and expects commercial premium yields of 7% to 8% to help the ratio improve in 1999. Balance sheet and cash flow are solid: operating cash flow exceeded $1.0 billion, cash and investments totaled $4.4 billion, and the company redeemed $500 million of convertible preferred stock and repurchased 11.3 million shares. Debt rose to $708 million, and only about $500 million of cash and investments was available for general corporate use. Pending securities class actions tied to the 1998 Medicare disclosures, with the stock falling from $52 7/8 to $37 7/8 in one day in August 1998, add legal risk.
Mar 31, 1999
1996-A
UNITEDHEALTH GROUP INC Annual Report (Amendment), Year Ended Dec 31, 1996
This Form 10-K/A-1 from United HealthCare Corporation (the filing names the registrant as United HealthCare Corporation, ticker UNH on the New York Stock Exchange) covers the fiscal year ended December 31, 1996. The filing is an amendment that principally updates the exhibit index. It reports 185,600,404 shares of common stock, $.01 par value, issued and outstanding as of March 17, 1997, and an aggregate market value held by non-affiliates of approximately $7,957,874,400 based on a $50 per share sale price on March 1, 1997. The filing's body incorporates financial information by reference. Its Exhibit 13 is the Annual Report to Shareholders, covering Investor Information, Financial Highlights, Financial Review and the Consolidated Financial Statements with the Report of Independent Public Accountants. Those financial details are not reproduced in this filing text, so the substance of the company's 1996 results is not stated here. Other exhibits listed include a Statement regarding computation of per share earnings (Exhibit 11), a Subsidiaries list (Exhibit 21), a Consent of Independent Public Accountants (Exhibit 23), Powers of Attorney (Exhibit 24) and a Financial Data Schedule (Exhibit 27). The amendment lists new or refreshed executive and benefit arrangements, including an amended and restated 1991 Stock and Incentive Plan effective August 15, 1996, a new employment agreement with David A. George effective October 2, 1995, and an AARP Health Insurance Agreement dated February 26, 1997. Certain confidential portions of several exhibits were deleted under Rule 24b-2 and filed separately with the SEC.
Jun 16, 1997
1996
UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 1996
United HealthCare Corporation (NYSE: UNH) reported a strong but margin-pressured 1996 in its FY1996 Form 10-K. Revenues rose 78% to $10.07 billion, driven largely by the October 1995 MetraHealth acquisition and other 1996 deals, while net earnings grew 24% to $355.6 million, or $1.76 per share. Excluding merger costs and a $45 million provision for losses on two St. Louis contracts, adjusted net earnings were $392.2 million ($1.96 per share), though the filing shows adjusted net operating earnings up only 2% year over year. The core concern for investors is the medical expense ratio, which rose to 84.6% from 79.7% in 1995, reflecting a 3-4% commercial health cost trend that outpaced the 1-2% pricing assumed in late 1995 and early 1996 renewals. The balance sheet and cash flow look solid. Cash and investments grew to $3.45 billion, operating cash flow was $562 million, and shareholders' equity reached $3.82 billion. Total assets rose to $7.0 billion, with goodwill and intangibles of $2.14 billion from acquisitions, which makes acquisition integration and intangible valuation important risks. Management says premium rate increases of 4-5% at renewal since February 1996 have improved the pricing environment, but it does not guarantee that trend will continue. Looking ahead, the 10-year AARP Medicare supplement contract, expected to contribute about $4.0 billion in annual premium revenue starting January 1998, is a major growth driver. Its success depends on servicing new members and pricing competitively, and the filing notes ongoing Medicare start-up losses and regulatory exposure.
Mar 28, 1997